Sires Introduces Legislation to Support Global Health Research and Development
(Washington, D.C.)—Today, Congressman Albio Sires introduced the Global Health Innovation Act, to encourage the development of health products that are affordable, culturally appropriate, and easy to use in low-resource health systems. This bill will require the U.S. Agency for International Development (USAID) to submit a report on the development and use of global health innovations at the Agency.
“I am happy to announce the reintroduction of this legislation with bipartisan support from my good friend from Florida, Congressman Mario Diaz-Balart. Each year, millions of people in the developing world die of infectious diseases, malnutrition, and complications of pregnancy and childbirth. Sadly, many of these deaths are preventable and I believe we must do what we can to save these lives.
Investing in global health isn’t just the right thing to do but a winning strategy for US businesses. 89 cents of every dollar the U.S. government invests in global health research and development benefits U.S. based researchers and between 2007 and 2015 these investments created 200,000 new jobs and created $33 billion in economic growth.” said Congressman Sires.
Through USAID, the federal government is addressing the need for global health technologies by facilitating public-private partnerships to develop affordable and appropriate health technologies. The critical research and development of global health technologies has facilitated the development of life-saving technologies saving countless lives across the globe. The Global Health Innovation Act supports a long-term program to develop these much needed health technologies and innovative and easy to use health solutions for low resource environments
Rep. Mario Diaz-Balart stated, “I am proud to reintroduce this critical piece of legislation with my friend, Rep. Albio Sires. It is more important than ever that the United States invest in global health and continue to deliver state-of-the-art medical devices and technologies. The Global Health Innovation Act will allow Congress to continue to oversee the effectiveness and development of these life-saving products and ensure taxpayer dollars are spent wisely.”
The Global Health Innovation Act passed the House of Representatives in the 114th Congress but did not come up for a vote in the Senate.